Literature DB >> 18202251

Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation.

Andrew J Kerr1, O Christopher Raffel, Gillian A Whalley, Irene Zeng, Ralph A Stewart.   

Abstract

AIMS: To determine whether elevated B-type natriuretic peptide (BNP) predicts left ventricular (LV) contractile dysfunction on exercise stress echocardiography in patients with severe mitral regurgitation (MR). METHODS AND
RESULTS: Thirty three patients with moderate-to-severe or severe MR, a LV ejection fraction > or =60% and New York Heart Association Class I or II symptoms, and 12 controls underwent resting and exercise stress echocardiography. In 20 MR patients, BNP was within the normal range (mean +/- SD, 7.7 +/- 2.7 pmol/L), and in 13 MR patients, BNP was >12 pmol/L (19.6 +/- 7.6 pmol/L). LV end-systolic volume index after exercise was lower in controls than patients with MR (P < 0.0001), but similar in MR patients with normal and elevated BNP, respectively (controls 8.5 +/- 3.9, MR 20 +/- 7 vs. 20 +/- 9 cm(2)/m(2), P > 0.05). However, pulmonary artery systolic pressure (PAP) after exercise was higher in MR with high BNP (70 +/- 20 vs. 48 +/- 11 mmHg, <0.0001) and controls (38+/-11 mmHg). A two-fold increase in plasma BNP was associated with an average increase in resting PAP of 7.6 (95% CI 2.9, 12.2) mmHg, an increase in post-exercise PAP of 14.4 (95% CI 9.0, 19.9) mmHg and increase in left atrial area index of 2.1 (95% CI 0.5, 3.8) cm(2)/m(2). However, there was no significant association between the plasma level of BNP and any rest or post-exercise measure of LV systolic function (r < 0.25, P > 0.05 for all).
CONCLUSION: The plasma level of BNP may be within the normal range in patients with moderate-to-severe or severe MR despite significant increases in LV end-systolic volume. Increase in BNP is associated with pulmonary artery hypertension on exercise and left atrial enlargement even when LV systolic function on exercise stress echocardiography is normal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202251     DOI: 10.1093/eurheartj/ehm553

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

Review 1.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 2.  Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.

Authors:  Daniel E Forman; James A de Lemos; Leslee J Shaw; David B Reuben; Radmila Lyubarova; Eric D Peterson; John A Spertus; Susan Zieman; Marcel E Salive; Michael W Rich
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

3.  Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure.

Authors:  M Feola; L Valeri; E Menditto; E Nervo; F Bianco; N Aspromonte; R Valle; G Visconti
Journal:  J Endocrinol Invest       Date:  2010-02-15       Impact factor: 4.256

Review 4.  Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special Situations.

Authors: 
Journal:  Arq Bras Cardiol       Date:  2015-05-01       Impact factor: 2.000

5.  Plasma brain natriuretic peptide concentrations in patients with valvular heart disease.

Authors:  Vishal Sharma; Ralph A Stewart; Mildred Lee; Ruvin Gabriel; Niels Van Pelt; David E Newby; Andrew J Kerr
Journal:  Open Heart       Date:  2016-05-04

6.  Prognostic Importance of Exercise Brain Natriuretic Peptide in Asymptomatic Chronic Organic Severe Mitral Regurgitation: An Observational Study.

Authors:  Santosh Kumar Sinha; Shalini Garg; Ramesh Thakur; Vinay Krishna; Karandeep Singh; Mohit Sachan; Amit Goel; Mahamdula Razi; Umeshwar Pandey; Chandra Mohan Varma
Journal:  J Clin Med Res       Date:  2016-09-29

Review 7.  Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease.

Authors:  Abhishek Sharma; Vaseem Ahmed; Aakash Garg; Chirag Aggarwal
Journal:  Dis Markers       Date:  2015-07-22       Impact factor: 3.434

8.  B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.

Authors:  Eman M Abdel Fattah; Hany Younan Azer Girgis; Khaled El Khashab; Zeinab A Ashour; Ghada M Ezzat
Journal:  Heart Views       Date:  2016 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.